Posts Tagged: "Merck patents"

Merck subsidiary Idenix wins $2.54B in HCV treatment suit against Gilead in largest U.S. patent infringement verdict ever

On Thursday, December 15th, a subsidiary of Kenilworth, NJ-based pharmaceutical developer Merck & Co. (NYSE:MRK) was awarded $2.54 in royalty damages in a case involving one of the most popular available treatments for combating the hepatitis C virus (HCV). A federal jury decided that Gilead Sciences Inc. (NASDAQ:GILD), an American biotech firm headquartered in Foster City, CA, owed these royalties as a result of its infringement of patents for HCV treatments held by Merck’s Cambridge, MA-based subsidiary Idenix Pharmaceuticals. According to coverage of the verdict by Bloomberg, this $2.54 billion royalties award is the largest verdict for patent infringement in the history of the United States. The case was decided by jury in the U.S. District Court for the District of Delaware (D. Del.).

Steve Brachmann

January 5, 2017

Merck, Pfizer and Eli Lilly patenting to stay ahead of patent cliff

The early months of 2015 have been interesting ones for the pharmaceutical industry, an incredibly valuable industry sector that comes under our focus from time to time here at IPWatchdog. The first quarter of this calendar year has seen a number of mergers and acquisitions which are showing us that the patent market for pharmaceuticals is quite active right now.…

Steve Brachmann

April 10, 2015

Merck seeks patents on cancer treatments, medications for Alzheimer’s

Merck & Co. (NYSE: MRK), which is headquartered in Whitehouse Station, NJ, and also does business under the name Merck Sharp & Dohme MSD, is one of the world’s largest and most renowned pharmaceutical development companies. The company just made a major acquisition in the middle of December, investing $8.4 billion in the purchase of Cubist Pharmaceuticals, a deal which…

Steve Brachmann

January 21, 2015

Top 10 Patents for 2014

Today, we’re picking the best inventions for which corporations from the Companies We Follow series have actually earned patent rights from the U.S. Patent and Trademark Office. Alternative energies, drones, robots, seawater desalination and the Internet of Things all make an appearance in today’s profile of the best inventions from the past year.

Steve Brachmann

December 30, 2014

Merck Patents Drugs for Metabolic Disorders & Alzheimer’s

Our survey of the patents recently issued by the USPTO to Merck showed us a great deal of innovation in the field of metabolic disorders and conditions, especially obesity-related diabetes. But one particular patent issued to Merck now protects a pharmaceutical compound inhibiting the activity of gamma secretase and other enzymes involved in the production of amyloid beta. It’s believed that reductions in amyloid protein can treat or even prevent Alzheimer’s disease, making it a very important area of medical research.

Steve Brachmann

September 15, 2014